HQY stock forecast, quote, news & analysis
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions... Show more
HealthEquity, Inc. (HQY) Stock Analysis: HSA Momentum Builds Investor Interest
Key Takeaways
- HealthEquity reported record fiscal 2026 revenue and earnings, prompting an upward revision to its fiscal 2027 outlook.
- Recent board appointment and analyst upgrades, including from BMO Capital, reflect confidence in long-term growth prospects.
- Upcoming first-quarter earnings release on May 28, 2026, represents a key near-term catalyst for the stock.
- Health savings account (HSA) adoption trends and operational metrics continue to support the company's market position.
- Analyst consensus remains positive, with multiple firms maintaining Buy ratings amid broader healthcare sector dynamics.
Current Market Snapshot
In recent weeks, HealthEquity, Inc. (HQY) has traded within a range influenced by broader market sentiment toward healthcare technology and financial services stocks. The shares have reflected steady investor attention following strong prior-period results and forward-looking guidance updates. Trading volumes have remained consistent with typical patterns for the name, while price movements have aligned with sector rotation themes and macroeconomic signals affecting growth-oriented equities. The stock continues to draw interest from those monitoring healthcare savings platforms amid evolving consumer and employer adoption trends.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing automated trading systems designed for various market conditions. While Tickeron offers hundreds of AI trading bots capable of executing strategies across thousands of tickers, only those demonstrating the strongest suitability and performance metrics earn placement in this trending section. Available bots feature diverse trading styles, strategies, timeframes, and performance statistics, allowing users to identify options aligned with specific risk profiles and market environments. The platform highlights ranges of historical returns and win rates to help investors evaluate suitability. For a closer look at current selections, visit Trending AI Robots.
Recent Developments Driving HQY Price Action
HealthEquity delivered standout fiscal 2026 results, with revenue rising 9% to $1.31 billion and net income surging 123% to $215.2 million. These figures, reported in mid-March, included a notable increase in new health savings accounts (HSAs) from sales activity, contributing to a raised fiscal 2027 outlook that supported positive sentiment. The strong earnings performance and margin expansion helped anchor investor confidence, with shares showing resilience in subsequent sessions despite broader market fluctuations.
On March 30, 2026, the company appointed Sanford Health CEO Bill Gassen to its board of directors. This addition brings healthcare operational expertise at a time when HealthEquity continues to expand its platform serving consumers and employers. The move was viewed as a strategic enhancement, reinforcing leadership depth without immediate material impact on near-term financials but supporting longer-term positioning.
On May 5, 2026, HealthEquity announced the date for its first-quarter earnings release and outlined upcoming investor conference participation. The scheduled report on May 28, 2026, has become a focal point, with market participants monitoring for updates on HSA asset growth, revenue trends, and any refinements to guidance. Pre-earnings positioning has contributed to measured price action in recent trading sessions.
Analyst activity has remained constructive. BMO Capital upgraded the stock, citing an improved long-term growth outlook and raising its price target. Wells Fargo reaffirmed its Buy rating, aligning with a broader consensus that views the company favorably. These actions have helped sustain interest, particularly as macroeconomic factors such as interest rate expectations and healthcare spending patterns influence the sector.
Additional context includes ongoing industry tailwinds from rising HSA adoption, with younger demographics showing increased engagement. No major regulatory or acquisition developments emerged in the period, keeping focus on organic execution and earnings delivery. Overall, price behavior has mirrored the balance between confirmed operational strength from the prior fiscal year and anticipation around fresh quarterly data.
2026 Outlook and Key Factors to Monitor
As HealthEquity enters the remainder of calendar 2026, investors may track several themes tied to its core HSA and benefits platform. Continued growth in account numbers and assets under management will remain central, alongside metrics such as average account balances and member engagement. Operational efficiency, including cost management and technology investments, could influence margin trajectories.
Broader industry trends, including shifts in employer-sponsored benefits and consumer preferences for tax-advantaged savings vehicles, warrant attention. Macroeconomic conditions affecting healthcare utilization and wage growth may also play a role in adoption rates. Regulatory developments around health savings accounts or related financial products could introduce variability.
Competitive positioning against other benefits administrators and potential evolution in product offerings represent additional areas for observation. Management commentary on fiscal 2027 execution and any updates to capital allocation priorities will provide further context. These elements collectively shape the environment in which the company operates through the year.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HQY in -1.54% downward trend, declining for three consecutive days on June 12, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HQY declined for three days, in of 264 cases, the price declined further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for HQY turned negative on June 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
HQY broke above its upper Bollinger Band on May 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where HQY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 12, 2026. You may want to consider a long position or call options on HQY as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
HQY moved above its 50-day moving average on May 13, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQY advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 274 cases where HQY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HQY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.608) is normal, around the industry mean (7.394). P/E Ratio (33.086) is within average values for comparable stocks, (50.081). Projected Growth (PEG Ratio) (1.265) is also within normal values, averaging (1.188). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (5.721) is also within normal values, averaging (5.606).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HQY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of solutions for managing health care accounts
Industry ServicestotheHealthIndustry